Contents:

1. Analyst View 2. Research Overview 3. Industry Overview 3.1 Biotechnology Industry Worldwide 3.2 US Biotech Industry 4. Industry Performance 4.1 Bio Medical 4.1.1 Current Biomedical Business Models 4.1.1.1 Fully Integrated Companies (FICOs: FIPCOs, FIBCOs, FICOPs) 4.1.1.2 Non Research Development Only (NRDOs) 4.1.1.3 Platform Model 4.1.1.4 Mixed Models 4.1.1.5 Medical Device Model 4.1.2 Stages of Growing Biomedical Firm 4.2 Agriculture Biotechnology 4.2.1 Production and Economic Impacts 4.2.2 Adoption of Biotechnology Derived Crops 4.2.3 Biotechnology and Biofuels 4.3 Clinical Trials 4.4 Mergers and Acquisitions 4.5 Strategic Alliances 4.6 Biotech Funding (Public, Private & Venture Capital) 4.7 Biotech Research Parks 4.7.1 Cummings Research Park, Huntsville 4.7.2 ASU (Arizona State University) Research Park 4.7.3 Texas Research Park 4.7.4 Delaware Technology Park 4.7.5 Massachusetts Biotechnology Research Park 4.7.6 UK (University of Kentucky) Coldstream Research Campus 4.7.7 InterTech Science Park 4.7.8 Chicago Technology Park 5. US Bio Cluster 5.1 New York 5.2 North-West Pennsylvania 5.3 Massachusetts 5.4 California 5.5 Washington 6. Industry Analysis 6.1 Key Drivers 6.1.1 Increasing Financing Option 6.1.2 Strong and Stable Biotech Sector 6.1.3 Environmental Drivers 6.1.4 Sociological Drivers 6.1.5 Patent System 6.1.6 Federal Funding 6.1.7 FDA Biopharmaceuticals Approvals 6.1.8 Technology 6.2 Opportunities 6.2.1 Opportunity for Developers of Innovative Health Solutions 6.2.2 Biofertilizers/BioPesticides 6.2.3 Agricultural Biotechnology 6.2.4 Biofuel 6.3 Challenges 6.3.1 Consumer Preferences & Market Uncertainty 6.3.2 Cost Pressures 6.3.3 Competition from Developing Countries like India & China 6.3.4 Public Acceptance 6.4 Future Outlook, 2010 7. Key Players and Company Profiles 7.1 Chiron Corporation 7.2 Amgen Inc. 7.3 Biogen Idec, Inc. 7.4 Applied Biosystems 7.5 Genentech 7.6 Baxter International Inc. 8. Annexure I: Government Initiatives and Regulations 8.1 Food and Drug Administration (FDA) 8.1.1 Food 8.1.2 Regulation of Drugs and Biologic Products 8.2 United States Department of Agriculture (USDA) 8.3 United States Environmental Protection Agency (USEPA) List of Tables Table 3-1: Biotechnology Industry Segments and Applications Table 4-1: US - Regulatory History of Biomedical Industry Table 4-2: US - Stages for Biomedical Companies Table 4-3: US - Overall Impact of Biotechnology Derived Crops on Agriculture (2001 & 2003 to 2005) Table 4-4: US - Percentage Adoption of Biotechnology Derived Crops (2003-2005) Table 4-5: US - Impact of Biotechnology on Crops (Production & Pesticides Reduction), 2005 Table 4-6: US - Impact of Agricultural Biotechnology on Crops, 2005 Table 4-7: US - Impact of Bitechnology Corn on Grain and Ethanol Production (1996-2005) Table 4-8: US - Selected Biotech M&As (in Million US$), 2005 Table 4-9: US - Biotech Alliances (in Million US$), 2005 Table 4-10: US - Biotech Financing (in Million US$), 2004 & 2005 Table 5-1: Massachusetts - List of FDA Approved Biotechnology Products Table 6-1: US - FDA Approvals by Drug Name, Company & Type Table 7-1: Amgen Inc. - Key Financials (in Million US$), 2004 to Sep’ 2006 Table 7-2: Biogen Idec, Inc. - Key Financials (in Million US$), 2004 to Sep’ 2006 Table 7-3: Applied Biosystems - Key Financials (in Billion US$), June’ 2006 Table 7-4: Genentech - Key Financials (in Million US$), 2004 to Sep’ 2006 Table 7-5: Baxter International Inc. - Key Financials (in Million US$), 2005 & Sep’ 2006 Table 8-1: US - Federal Biotechnology Regulatory Framework List of Figures Figure 3-1: Global - Biotechnology Market (in Billion US$), 2001-2005 Figure 3-2: Global - Biotechnology Market Share by Region (%), 2005 Figure 3-3: Global - Biotechnology Market Share by Segment (%), 2005 Figure 3-4: Global - Forecast for Biotechnology Market (in Billion US$), 2006-2010 Figure 3-5: US - Biotechnology Market (in Billion US$), 2001-2006E Figure 3-6: US - Biotechnology Market Share by Segment (%), 2005 Figure 3-7: US - Distribution Companies by Segment (%), 2005 Figure 4-1: US - Net Loss Relative to Revenue (%), 1991-2005 Figure 4-2: US - Employment in Biomedical Sector (%), 2005 Figure 4-3: US - Interaction among Players in Biomedical and Healthcare Industries Figure 4-4: US - Forecast for Clinical Trial Industry (in Billion US$), 2006-2011 Figure 4-5: US - Clinical Trials (in Numbers), 2003-2006E Figure 4-6: US - Forecast for Clinical Trials (in Number), 2007-2011 Figure 4-7: US - Biotech Financing (in Billion US$), 2004-2006E Figure 6-1: US - Biotech Financing (in Billion US$), 2004 & 2005 Figure 6-2: US - FDA Approvals (in Numbers), 2000 to Jun’ 2006 Figure 6-3: US - Ethanol Demand (in Billion Gallons), 2006-2008E Figure 6-4: US - Forecast for Biotech Market (in Billion US$), 2007-2010

Companies Mentioned

- Chiron Corporation - Amgen Inc. - Biogen Idec, Inc. - Applied Biosystems - Genentech - Baxter International Inc.